Healthcare Venture Funding and Entrepreneurship Meetings

The following series of events on healthcare funding and entrepreneurship is generally reserved to members of the Yale community. But let me know if you are interested and we may be able to provide access either directly or through a video link.

Gus Lawlor, Managing Director of HealthCare Ventures, one of the top VC firms in healthcare, will be meeting with interested members of the SOM and greater Yale Healthcare communities on Saturday, Feb. 22 at 3 PM. I’ll let you know the exact room based on how many responses I get. I think this is going to be a great meeting for us all.

Gus Lawlor has been a managing director of HealthCare Ventures since 2000. He was previously chief operating officer of LeukoSite, Inc., a HealthCare Ventures III, IV, and V company. Before joining LeukoSite, he was chief financial officer and vice president of corporate development for Alpha-Beta Technology. He held similar positions at BioSurface Technology and Armstrong Pharmaceuticals. He was previously a management consultant with KPMG Peat Marwick. Mr. Lawlor is a member of the board of directors of the Slater Center in Providence, Rhode Island. He received a Master’s degree in Public and Private Management from Yale School of Management and is the father of a current Yale student.

  • Gus has asked us to take a look at two articles in order to make for a productive discussion (we don’t need to be class-ready, just familiar). They’re around $6 per licensed copy.
  1. Father’s Love: Novazyme, HBS Case #603048. Gus was a founding investor in Novazyme and wants to give the back story.
  2. Structuring Deals and Governance After the IPO: Entrepreneurs and Venture Capitalists in High Tech Start-Ups .

Further out:

  • Dick Foster will meet with us on Friday, April 4 (6 PM at Evans, dinner will be available). Dick started the healthcare practice at McKinsey and is now a managing partner at Millbrook Ventures, a healthcare VC firm in NYC. Dick is especially interested in HIT investments. Author of two bestselling books on innovation (here and here). He is also a member of the Yale School of Management faculty, among many other pursuits. He is especially interested in meeting with members of the EMBA community, but if you aren’t an EMBA student you are very welcome to attend, with RSVP. Light dinner fare will be available.
  • Susan Froshauer, President of CURE, will be meeting with us on May 3 (3 PM, at Evans). CURE is a non-profit focused on developing life-science ventures in Connecticut by bringing together academics, non-profits and bioscience companies. Until 2010, Susan served as President and CEO of Rib-X Pharmaceuticals (now Melinta), which she co-founded in New Haven in 2000. Under her leadership, Rib-X raised more than $160 million in private equity, bridge financing and government grants and built a robust pipeline of antibiotics to treat serious hospital infections.

Let us know your interest in attending any of these events either directly or by video.


What? Patients like to understand?

PCMH may foster communication and satisfaction….